GNI Group Ltd. (TYO:2160)
Japan · Delayed Price · Currency is JPY 3,385.00
+15.00 (0.45%)
Apr 20, 2026, 9:00 AM JST
GNI Group Market Cap
GNI Group has a market cap or net worth of 187.66 billion as of April 17, 2026. Its market cap has increased by 69.20% in one year.
Market Cap
187.66B
Enterprise Value
173.44B
Revenue
26.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,385.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 187.66B, an increase of 3,484.17%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 187.66B | 39.79% |
| Dec 30, 2025 | 134.25B | -21.38% |
| Dec 30, 2024 | 170.75B | 21.35% |
| Dec 29, 2023 | 140.72B | 112.73% |
| Dec 30, 2022 | 66.15B | -5.89% |
| Dec 30, 2021 | 70.29B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 163.17B |
| PeptiDream | 152.80B |
| Takara Bio | 137.51B |
| Nxera Pharma | 91.67B |
| Oncolys BioPharma | 83.72B |
| Cuorips | 58.22B |
| Healios K.K. | 49.95B |
| Japan Tissue Engineering | 24.65B |